|  | Presence of the considered lesion | Absence of the considered lesion | ||||
---|---|---|---|---|---|---|---|
Histological changes | No. of samples | Mean ± SD | Median | Range | Mean ± SD | Median | Range |
No relevant findings | 6 | 36 ± 15.73 | 33.15 | 20.04–62.54 | 46.77 ± 22.05 | 46.43 | 17.86–110.97 |
Glomerulosclerosis | 10 | 51.41 ± 32.67 | 49.92 | 17.86–110.97 | 41.23 ± 11.8 | 43.25 | 17.86–110.97 |
Proximal tubular lipidosis | 24 | 47.79 ± 22,76 | 46.67 | 17.76–110.97 | 34.16 ± 10.57 | 33.83 | 22.94–48.57 |
Tubular atrophy | 5 | 34.75 ± 7.87 | 34.19 | 24.5–46.67 | 46.6 ± 22.46 | 46.18 | 17.86–110.97 |
Fibrosis* | 2 | 104.9 ± 8.52 | 104.9 | 98.84–110.97 | 40.32 ± 13.72 | 43.25 | 17.86–62.54 |
Tubular vacuolar *degeneration | 15 | 56.18 ± 21.93 | 51.27 | 23.64–110.97 | 33.06 ± 12.54 | 34.06 | 17.86–62.54 |
Glomerular atrophy | 9 | 41.6 ± 10.18 | 43.61 | 22.94–54.8 | 45.92 ± 24.5 | 44.13 | 17.86–110.97 |
Interstitial nephritis* | 5 | 75.77 ± 27.24 | 60.01 | 49.67–110.97 | 38.39 ± 13.15 | 37.57 | 17.86–62.54 |
Glomerulonephritis* | 2 | 18.76 ± 1.2 | 18.76 | 17.86–19.67 | 46.47 ± 20.64 | 45.15 | 20.05–110.97 |